Back to BCRX
HUSSMAN STRATEGIC ADVISORS, INC. → BCRX
HUSSMAN STRATEGIC ADVISORS, INC. BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$1.2M
Q3 2026
Peak value
$2.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.6M |
| Q4 2025 | $2M |
| Q2 2026 | $2.1M |
| Q3 2026 | $1.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.2M | 147.0K | — | — |
| Q2 2026 | $2.1M | 210.0K | — | — |
| Q4 2025 | $2M | 252.0K | — | — |
| Q3 2025 | $1.6M | 210.0K | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M